Characterization of innate lymphoid cells in human skin and blood demonstrates increase of NKp44+ ILC3 in psoriasis

Journal of Investigative Dermatology

Volumn 134, Issue 4, 2014, Pages 984-991

  Villanova, Federica ^a,b   Flutter, Barry ^a   Tosi, Isabella ^a,b   Grys, Katarzyna ^a,b   Sreeneebus, Hemawtee ^a,b   Perera, Gayathri K ^a,c   Chapman, Anna ^d   Smith, Catherine H ^a   Di Meglio, Paola ^a,e   Nestle, Frank O ^a,b  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b GUY'S AND ST THOMAS' NHS FOUNDATION TRUST   (United Kingdom)

^c MIDDLESEX HOSPITAL   (United Kingdom)

^d QUEEN ELIZABETH HOSPITAL   (United Kingdom)

^e NATIONAL INSTITUTE FOR MEDICAL RESEARCH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADALIMUMAB; INTERLEUKIN 17; INTERLEUKIN 22; INTERLEUKIN 23; NATURAL CYTOTOXICITY TRIGGERING RECEPTOR 2;

ADULT; ARTICLE; CELL POPULATION; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOPHENOTYPING; IMMUNOTHERAPY; INNATE LYMPHOID CELL; LYMPHOID CELL; MALE; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PSORIASIS; SKIN BIOPSY;

ADULT; ANTIGENS, CD3; BIOLOGICAL MARKERS; DERMATITIS, ATOPIC; FEMALE; FLOW CYTOMETRY; GENE EXPRESSION REGULATION; HOMEOSTASIS; HUMANS; IMMUNITY, INNATE; IMMUNOPHENOTYPING; INTERLEUKIN-17; INTERLEUKINS; LEUKOCYTES, MONONUCLEAR; LYMPHOCYTES; MALE; MIDDLE AGED; NATURAL CYTOTOXICITY TRIGGERING RECEPTOR 2; PSORIASIS; SKIN;

EID: 84897045234     PISSN: 0022202X     EISSN: 15231747     Source Type: Journal    
DOI: 10.1038/jid.2013.477     Document Type: Article

References (26)

1. Bernink JH, Peters CP, Munneke M et al. (2013) Human type 1 lymphoid cells accumulate in inflamed mucosal tissues. Nat Immunol 14:221-9
2. Boyman O, Conrad C, Tonel G et al. (2007) The pathogenic role of tissue-resident immune cells in psoriasis. Trends Immunol 28:51-7
3. Boyman O, Hefti HP, Conrad C et al. (2004) Spontaneous development of psoriasis in a new animal model shows an essential role for resident T cells and tumor necrosis factor-alpha. J Exp Med 199:731-6
4. Cella M, Fuchs A, Vermi W et al. (2009) A human natural killer cell subset provides an innate source of IL-22 for mucosal immunity. Nature 457:722-5
5. Clark RA (2010) Skin-resident T cells: the ups and downs of on site immunity. J Invest Dermatol 130:362-70
6. Di Cesare A, Di Meglio P, Nestle FO (2009) The IL-23/Th17 axis in the immunopathogenesis of psoriasis. J Invest Dermatol 129:1339-50
7. Di Meglio P, Perera GK, Nestle FO (2011) The multitasking organ: recent insights into skin immune function. Immunity 35:857-69
8. Diveu C, McGeachy MJ, Cua DJ (2008) Cytokines that regulate autoimmunity. Curr Opin Immunol 20:663-8
9. Gebhardt T, Wakim LM, Eidsmo L et al. (2009) Memory T cells in nonlymphoid tissue that provide enhanced local immunity during infection with herpes simplex virus. Nat Immunol 10:524-30
10. Geremia A, Arancibia-Carcamo CV, Fleming MP et al. (2011) IL-23-responsive innate lymphoid cells are increased in inflammatory bowel disease. J Exp Med 208:1127-33
11. Griffiths CE, Barker JN (2007) Pathogenesis and clinical features of psoriasis. Lancet 370:263-71
12. Hijnen D, Knol EF, Gent YY et al. (2013) CD8(+) T cells in the lesional skin of atopic dermatitis and psoriasis patients are an important source of IFN-gamma, IL-13, IL-17, and IL-22. J Invest Dermatol 133: 973-9
13. Hoorweg K, Peters CP, Cornelissen F et al. (2012) Functional differences between human NKp44(-) and NKp44(+) RORC(+) innate lymphoid cells. Front Immunol 3:72
14. Jiang X, Clark RA, Liu L et al. (2012) Skin infection generates non-migratory memory CD8+ T(RM) cells providing global skin immunity. Nature 483:227-31
15. Kim BS, Siracusa MC, Saenz SA et al. (2013) TSLP elicits IL-33-independent innate lymphoid cell responses to promote skin inflammation. Sci Transl Med 5:170ra16
16. KupperTS, Fuhlbrigge RC (2004) Immune surveillance in the skin: mechanisms and clinical consequences. Nat Rev Immunol 4:211-22
17. Laggner U, Di Meglio P, Perera GK et al. (2011) Identification of a novel proinflammatory human skin-homing Vgamma9Vdelta2 T cell subset with a potential role in psoriasis. J Immunol 187:2783-93
18. Lowes MA, Russell CB, Martin DA et al. (2013) The IL-23/T17 pathogenic axis in psoriasis is amplified by keratinocyte responses. Trends Immunol 34:174-81
19. Nestle FO, Kaplan DH, Barker J (2009) Psoriasis. N Engl J Med 361: 496-509
20. Pantelyushin S, Haak S, Ingold B et al. (2012) Rorgammat+ innate lymphocytes and gammadelta T cells initiate psoriasiform plaque formation in mice. J Clin Invest 122:2252-6
21. Powell N, Walker AW, Stolarczyk E et al. (2012) The transcription factor T-bet regulates intestinal inflammation mediated by interleukin-7 receptor + innate lymphoid cells. Immunity 37:674-84
22. Spits H, Artis D, Colonna M et al. (2013) Innate lymphoid cells-a proposal for uniform nomenclature. Nat Rev Immunol 13:145-9
23. Takatori H, Kanno Y, Watford WT et al. (2009) Lymphoid tissue inducer-like cells are an innate source of IL-17 and IL-22. J Exp Med 206:35-41
24. Tsoi LC, Spain SL, Knight J et al. (2012) Identification of 15 new psoriasis susceptibility loci highlights the role of innate immunity. Nat Genet 44:1341-8
25. Villanova F, Di Meglio P, Inokuma M et al. (2013) Integration of lyoplate based flow cytometry and computational analysis for standardized immunological biomarker discovery. PLoS One 8:e65485
26. Yokota Y, Mansouri A, Mori S et al. (1999) Development of peripheral lymphoid organs and natural killer cells depends on the helix-loop-helix inhibitor Id2. Nature 397:702-6